Abbott India is currently trading at Rs. 7750.00, up by 149.50 points or 1.97% from its previous closing of Rs. 7600.50 on the BSE.
The scrip opened at Rs. 7630.00 and has touched a high and low of Rs. 7778.95 and Rs. 7630.00 respectively. So far 310 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 8199.00 on 06-Aug-2018 and a 52 week low of Rs. 4035.00 on 18-Sep-2017.
Last one week high and low of the scrip stood at Rs. 8010.00 and Rs. 7514.15 respectively. The current market cap of the company is Rs. 16457.58 crore.
The promoters holding in the company stood at 74.99%, while Institutions and Non-Institutions held 9.30% and 15.72% respectively.
Abbott India is eyeing to launch around 100 products over the next five years with an aim to strengthen existing therapy areas such as gastroenterology, metabolics, vaccines, central nervous system and women's health. The company is also looking at strengthening its over-the-counter portfolio with a wider range of product formats. The company had launched 21 new products in the country during last fiscal year.
Abbott India is healthcare company that discovers, develops, manufactures and markets innovative products and services.
